FZD8
Basic information
Region (hg38): 10:35638246-35642296
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FZD8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 39 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 3 | 0 |
Variants in FZD8
This is a list of pathogenic ClinVar variants found in the FZD8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-35639391-G-C | not specified | Uncertain significance (Apr 12, 2022) | ||
10-35639394-G-A | not specified | Uncertain significance (Nov 04, 2022) | ||
10-35639466-C-A | not specified | Uncertain significance (Oct 06, 2023) | ||
10-35639485-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
10-35639493-C-T | not specified | Likely benign (Mar 11, 2022) | ||
10-35639524-T-C | not specified | Uncertain significance (Sep 27, 2022) | ||
10-35639539-C-T | not specified | Uncertain significance (Feb 09, 2023) | ||
10-35639544-A-C | not specified | Uncertain significance (Sep 12, 2023) | ||
10-35639547-G-A | not specified | Uncertain significance (May 24, 2024) | ||
10-35639705-G-A | Likely benign (Oct 01, 2022) | |||
10-35639708-C-A | not specified | Uncertain significance (Jun 30, 2022) | ||
10-35639751-C-T | not specified | Uncertain significance (Dec 21, 2021) | ||
10-35639925-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
10-35639936-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
10-35639991-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
10-35640132-G-A | not specified | Uncertain significance (Sep 29, 2022) | ||
10-35640202-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
10-35640220-A-T | not specified | Uncertain significance (Aug 10, 2021) | ||
10-35640322-G-C | not specified | Uncertain significance (Nov 06, 2023) | ||
10-35640330-G-A | not specified | Uncertain significance (Jun 05, 2023) | ||
10-35640337-C-G | not specified | Uncertain significance (Nov 30, 2022) | ||
10-35640342-G-A | not specified | Uncertain significance (Sep 28, 2022) | ||
10-35640342-G-C | not specified | Uncertain significance (Nov 30, 2022) | ||
10-35640613-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
10-35640637-G-A | not specified | Uncertain significance (Jan 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FZD8 | protein_coding | protein_coding | ENST00000374694 | 1 | 3186 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.790 | 0.210 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.17 | 189 | 357 | 0.529 | 0.0000168 | 4370 |
Missense in Polyphen | 42 | 132.7 | 0.31649 | 1503 | ||
Synonymous | -3.55 | 221 | 163 | 1.35 | 0.00000825 | 1513 |
Loss of Function | 3.32 | 3 | 18.3 | 0.164 | 7.91e-7 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for Wnt proteins. Component of the Wnt-Fzd- LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome- sized signalosomes. The beta-catenin canonical signaling pathway leads to the activation of disheveled proteins, inhibition of GSK- 3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Coreceptor along with RYK of Wnt proteins, such as WNT1. {ECO:0000269|PubMed:11448771}.;
- Pathway
- Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Breast cancer - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Basal cell carcinoma - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Wnt signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);WNT-Core;Mesodermal Commitment Pathway;Ectoderm Differentiation;Regulation of Wnt-B-catenin Signaling by Small Molecule Compounds;Association Between Physico-Chemical Features and Toxicity Associated Pathways;ESC Pluripotency Pathways;Wnt Signaling Pathway and Pluripotency;Wnt Signaling in Kidney Disease;EMT transition in Colorectal Cancer;Wnt Signaling Pathway;Signaling by GPCR;Signaling by WNT;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Regulation of FZD by ubiquitination;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;Asymmetric localization of PCP proteins;PCP/CE pathway;Beta-catenin independent WNT signaling;GPCR signaling-G alpha i;Wnt;Wnt Canonical;Wnt signaling network;TCF dependent signaling in response to WNT;Wnt Mammals
(Consensus)
Recessive Scores
- pRec
- 0.221
Intolerance Scores
- loftool
- 0.120
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.4
Haploinsufficiency Scores
- pHI
- 0.274
- hipred
- hipred_score
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.938
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fzd8
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- fzd8a
- Affected structure
- ceratobranchial cartilage
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;angiogenesis;G protein-coupled receptor signaling pathway;neuron differentiation;T cell differentiation in thymus;non-canonical Wnt signaling pathway;positive regulation of JUN kinase activity;positive regulation of transcription by RNA polymerase II;canonical Wnt signaling pathway
- Cellular component
- Golgi apparatus;plasma membrane;integral component of membrane;Wnt-Frizzled-LRP5/6 complex
- Molecular function
- G protein-coupled receptor activity;signaling receptor binding;protein binding;Wnt-protein binding;PDZ domain binding;ubiquitin protein ligase binding;Wnt-activated receptor activity